The system will be designed to treat post-amputation pain. The system will feature SPR’s proprietary method of percutaneously stimulating peripheral nerves. This involves the insertion of a very small medical wire or lead through the skin.
This NIH grant adds to a $2.8 million research grant from the U.S. Department of Defense for ongoing clinical trials that assess the safety and efficacy of SPR Therapeutics’ PNS therapy.
More articles on anesthesia:
Annual & hourly anesthesiologist pay: 8 statistics
Somnia Anesthesia calls for anesthesiologist of the year award nominations
Dr. Julian Gold named mayor of California’s Beverly Hills
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
